<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Cerebral <z:hpo ids='HP_0000006'>Autosomal Dominant</z:hpo> <z:e sem="disease" ids="C0852949" disease_type="Disease or Syndrome" abbrv="">Arteriopathy</z:e> with Subcortical <z:mpath ids='MPATH_124'>Infarcts</z:mpath> and <z:hpo ids='HP_0002352'>Leukoencephalopathy</z:hpo> (CADASIL) is considered a model of pure vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> (VD) because it occurs in young adults unlikely to have concomitant age and <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's Disease</z:e>-(AD-) related pathology </plain></SENT>
<SENT sid="1" pm="."><plain>CSF levels of β-amyloid 1-42 (Aβ42), total tau protein (t-tau), and phosphorylated tau-protein (p-tau), well accepted biomarkers of AD, were evaluated in 10 CADASIL patients, 22 AD patients, and 17 healthy age-matched subjects </plain></SENT>
<SENT sid="2" pm="."><plain>Innotest β-amyloid 1-42, Innotest hTAU-Ag, and Innotest Phospho-tau 181p sandwich enzyme-linked immunoassay were used to determine CSF biomarkers levels </plain></SENT>
<SENT sid="3" pm="."><plain>A case-control statistical analysis was carried out </plain></SENT>
<SENT sid="4" pm="."><plain>CSF Aβ42 levels were significantly lower in CADASIL patients and considerable overlap with AD whereas t-tau and p-tau levels were <z:mpath ids='MPATH_458'>normal</z:mpath> and significantly different with respect to AD </plain></SENT>
<SENT sid="5" pm="."><plain>A significant altered CSF biomarkers profile in a pure VD supports the use of CSF Aβ42, t-tau, and p-tau levels in the differential diagnosis of VD and AD </plain></SENT>
</text></document>